Who Optimizes SG&A Costs Better? Walgreens Boots Alliance, Inc. or Pharming Group N.V.

SG&A Cost Management: Walgreens vs. Pharming Group

__timestampPharming Group N.V.Walgreens Boots Alliance, Inc.
Wednesday, January 1, 2014404202517992000000
Thursday, January 1, 2015527955722400000000
Friday, January 1, 2016807391323910000000
Sunday, January 1, 20174486407323813000000
Monday, January 1, 20185348890424694000000
Tuesday, January 1, 20196589636123557000000
Wednesday, January 1, 20206996826725436000000
Friday, January 1, 20219204728124586000000
Saturday, January 1, 202213181900027295000000
Sunday, January 1, 20238750100034205000000
Monday, January 1, 202428113000000
Loading chart...

Data in motion

Optimizing SG&A Costs: A Tale of Two Companies

In the competitive world of pharmaceuticals and retail, managing Selling, General, and Administrative (SG&A) expenses is crucial for profitability. Walgreens Boots Alliance, Inc. and Pharming Group N.V. offer a fascinating study in contrasts. From 2014 to 2023, Walgreens consistently reported SG&A expenses in the range of $17.7 billion to $28.1 billion, reflecting its expansive global operations. In contrast, Pharming Group's expenses ranged from $4 million to $132 million, highlighting its more focused business model.

Despite the vast difference in scale, both companies have shown trends in optimizing these costs. Walgreens saw a steady increase, peaking in 2024, while Pharming Group experienced a significant rise in 2022, followed by a reduction in 2023. This data underscores the importance of strategic cost management in maintaining competitive advantage and profitability in their respective industries.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
17 Jan 2025